Physician profile
Jashvant Patel
NPI 1619955994
$6,167.86
in general payments reported to CMS, 2019-2025
23 companies · $1,096 in 2025
The $1,096 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $131 · 2021: $693 · 2022: $363 · 2023: $937 · 2024: $2,634 · 2025: $1,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,849 · Travel and Lodging: $520 · Education: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,848.66 |
| Travel and Lodging | $519.97 |
| Education | $298.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,119.53 | 2021-2025 | Accurian, Intellis Adaptivestim, Vanta Adaptivestim |
| Boston Scientific Corporation | $1,429.66 | 2020-2025 | Intracept |
| Biotronik Nro, INC. | $832.78 | 2024-2025 | Prospera |
| Tersera Therapeutics LLC | $510.04 | 2022-2025 | Prialt |
| Medtronic USA, INC. | $233.03 | 2019-2020 | |
| Abbvie INC. | $226.47 | 2021-2025 | |
| Vertos Medical, INC. | $137.58 | 2021-2023 | Mild Device Kit |
| Foundation Fusion Solutions, LLC | $100.48 | 2023-2025 | |
| Electronic Waveform Lab, INC. | $93.00 | 2025 | |
| Painteq LLC | $67.18 | 2022-2023 | Painteq |
| Si-Bone, INC. | $64.92 | 2019-2022 | |
| Pfizer INC. | $55.61 | 2019-2021 | |
| Abbott Laboratories | $47.44 | 2021-2023 | Proclaim |
| Depuy Synthes Sales INC. | $47.14 | 2019-2022 | |
| Vertiflex, INC. | $43.13 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $29.42 | 2021 | |
| Avanos Medical | $23.87 | 2024 | Genvisc 850 Sodium Hyaluronate |
| Vertex Pharmaceuticals Incorporated | $21.22 | 2025 | |
| Bioventus LLC | $20.08 | 2024 | Durolane |
| Supernus Pharmaceuticals, INC. | $20.05 | 2020 | |
| Almatica Pharma LLC | $18.76 | 2022 | |
| Horizon Therapeutics Plc | $14.03 | 2021 | |
| Ibsa Pharma INC. | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jashvant Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.